Valuation: Edwards Lifesciences Corporation

Market Cap 53.92B 47.29B 43.66B 40.35B 76.47B 5,163B 78B 525B 204B 2,526B 202B 198B 8,770B P/E 2026 *
33.4x
P/E 2027 * 28.6x
Enterprise Value 50.44B 44.24B 40.84B 37.74B 71.53B 4,829B 72.97B 491B 191B 2,363B 189B 185B 8,204B EV / Sales 2026 *
7.47x
EV / Sales 2027 * 6.59x
Free-Float
87.23%
Yield 2026 *
-
Yield 2027 * -
1 day-1.24%
1 week+1.79%
Current month+3.52%
1 month+9.07%
3 months+14.60%
6 months+10.71%
Current year+9.84%
1 week 92.72
Extreme 92.72
96.29
1 month 83.17
Extreme 83.17
96.29
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 11/05/2023
Director of Finance/CFO 43 29/05/2026
Chief Tech/Sci/R&D Officer 51 01/09/2025
Director TitleAgeSince
Chairman 69 07/05/2024
Director/Board Member 62 10/02/2015
Director/Board Member 58 11/05/2023
Date Insider Type Main position Quantity % Market Cap.
07-07Tax

Executive/Senior Manager

-377 0.0001%
06-30Fiscal year

Executive/Senior Manager

1,857 0.0003%
06-17Sell

Chief Executive Officer

-523 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.24%+1.79%+22.58%+3.74% 53.92B
-1.26%-0.62%+19.70%-0.70% 190B
-2.86%+3.16%-21.28%+25.30% 147B
-1.76%-1.52%-4.94%-18.15% 135B
-1.08%+4.06%-56.24%-14.30% 66.6B
+0.07%-1.83%-27.59%-30.96% 43.57B
-1.58%-3.24%+6.66%+10.32% 36.45B
-1.81%-2.64%+5.85%+39.36% 36.15B
-6.33%+2.36%-19.78%-4.62% 29.69B
-0.32%-0.28%-13.99%-18.76% 29.42B
Average -1.82%+1.06%-8.90%-0.88% 76.74B
Weighted average by Cap. -1.77%+1.55%-5.65%+0.19%

Financials

2026 *2027 *
Net sales 6.75B 5.92B 5.46B 5.05B 9.57B 646B 9.76B 65.69B 25.52B 316B 25.34B 24.79B 1,098B 7.41B 6.5B 6B 5.55B 10.51B 710B 10.72B 72.14B 28.03B 347B 27.83B 27.22B 1,205B
Net income 1.62B 1.42B 1.32B 1.22B 2.3B 156B 2.35B 15.81B 6.14B 76.11B 6.1B 5.97B 264B 1.89B 1.66B 1.53B 1.42B 2.68B 181B 2.74B 18.41B 7.15B 88.61B 7.1B 6.95B 308B
Net Debt -3.48B -3.05B -2.82B -2.61B -4.94B -333B -5.04B -33.9B -13.17B -163B -13.08B -12.79B -566B -5.07B -4.45B -4.11B -3.8B -7.19B -486B -7.34B -49.38B -19.19B -238B -19.05B -18.63B -825B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
08/07/26 US$93.64 -1.24% 3,673,430
07/07/26 US$94.82 -0.38% 4,445,101
06/07/26 US$95.18 +0.86% 3,958,057
02/07/26 US$94.37 +2.59% 3,206,400
01/07/26 US$91.99 +1.69% 4,284,007
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
93.64USD
Average target price
97.92USD
Spread / Average Target
+4.57%

Quarterly revenue - Rate of surprise